company background image
A206640 logo

Boditech Med KOSDAQ:A206640 Stock Report

Last Price

₩14.90k

Market Cap

₩327.4b

7D

-10.5%

1Y

-21.3%

Updated

09 Oct, 2024

Data

Company Financials +

Boditech Med Inc.

KOSDAQ:A206640 Stock Report

Market Cap: ₩327.4b

A206640 Stock Overview

Offers instruments and diagnostic reagents in South Korea and internationally.

About the company

A206640 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth2/6
Past Performance5/6
Financial Health6/6
Dividends3/6

Rewards

Trading at 56.8% below our estimate of its fair value
Earnings are forecast to grow 16.55% per year
Earnings grew by 34.6% over the past year
Trading at good value compared to peers and industry

Risk Analysis

Unstable dividend track record

Boditech Med Inc. Competitors

Value Added Technology

KOSDAQ:A043150

₩364.7b

InBodyLtd

KOSDAQ:A041830

₩315.9b

WON TECHLtd

KOSDAQ:A336570

₩586.9b

Vieworks

KOSDAQ:A100120

₩240.1b

Price History & Performance

Summary of all time highs, changes and price drops for Boditech Med
Historical stock prices
Current Share Price₩14,900.00
52 Week High₩22,150.00
52 Week Low₩13,400.00
Beta-0.67
11 Month Change-11.57%
3 Month Change-18.49%
1 Year Change-21.33%
33 Year Change-4.49%
5 Year Change69.13%
Change since IPO-73.22%

Recent News & Updates

Does Boditech Med (KOSDAQ:206640) Have A Healthy Balance Sheet?

Sep 13
Does Boditech Med (KOSDAQ:206640) Have A Healthy Balance Sheet?

Investor Optimism Abounds Boditech Med Inc. (KOSDAQ:206640) But Growth Is Lacking

Jul 12
Investor Optimism Abounds Boditech Med Inc. (KOSDAQ:206640) But Growth Is Lacking

Recent updates

Does Boditech Med (KOSDAQ:206640) Have A Healthy Balance Sheet?

Sep 13
Does Boditech Med (KOSDAQ:206640) Have A Healthy Balance Sheet?

Investor Optimism Abounds Boditech Med Inc. (KOSDAQ:206640) But Growth Is Lacking

Jul 12
Investor Optimism Abounds Boditech Med Inc. (KOSDAQ:206640) But Growth Is Lacking

Boditech Med Inc. (KOSDAQ:206640) Shares Fly 49% But Investors Aren't Buying For Growth

Apr 16
Boditech Med Inc. (KOSDAQ:206640) Shares Fly 49% But Investors Aren't Buying For Growth

Here's Why I Think Boditech Med (KOSDAQ:206640) Might Deserve Your Attention Today

Apr 13
Here's Why I Think Boditech Med (KOSDAQ:206640) Might Deserve Your Attention Today

Could The Market Be Wrong About Boditech Med Inc. (KOSDAQ:206640) Given Its Attractive Financial Prospects?

Mar 01
Could The Market Be Wrong About Boditech Med Inc. (KOSDAQ:206640) Given Its Attractive Financial Prospects?

Boditech Med (KOSDAQ:206640) Seems To Use Debt Rather Sparingly

Jan 18
Boditech Med (KOSDAQ:206640) Seems To Use Debt Rather Sparingly

Here's Why I Think Boditech Med (KOSDAQ:206640) Is An Interesting Stock

Dec 28
Here's Why I Think Boditech Med (KOSDAQ:206640) Is An Interesting Stock

Did Business Growth Power Boditech Med's (KOSDAQ:206640) Share Price Gain of 193%?

Dec 08
Did Business Growth Power Boditech Med's (KOSDAQ:206640) Share Price Gain of 193%?

Boditech Med Inc. (KOSDAQ:206640) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Nov 18
Boditech Med Inc. (KOSDAQ:206640) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Shareholder Returns

A206640KR Medical EquipmentKR Market
7D-10.5%-0.8%0.3%
1Y-21.3%28.4%6.4%

Return vs Industry: A206640 underperformed the KR Medical Equipment industry which returned 28.4% over the past year.

Return vs Market: A206640 underperformed the KR Market which returned 6.4% over the past year.

Price Volatility

Is A206640's price volatile compared to industry and market?
A206640 volatility
A206640 Average Weekly Movement7.8%
Medical Equipment Industry Average Movement8.1%
Market Average Movement6.8%
10% most volatile stocks in KR Market12.0%
10% least volatile stocks in KR Market3.5%

Stable Share Price: A206640 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A206640's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1998492n/awww.boditech.co.kr/en

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges; ichroma-50, an automated immunoassay system with high-throughput; Hemochroma PLUS, a handheld device that can run tests for anemia; portable analyzers ichroma M3 and ichroma M2; and NuActor, an automated nucleic acid extraction system. It also provides compact immunoassay analyzers, including AFIAS-1, AFIAS-3, AFIAS-6, and AFIAS-10; cardiac reagents; cancer reagents; COVID-19 reagents; diagnostic reagents; reagents for hormones, infections, autoimmune, organ functions, molecular diagnostics, therapeutic drug monitoring, and other test items.

Boditech Med Inc. Fundamentals Summary

How do Boditech Med's earnings and revenue compare to its market cap?
A206640 fundamental statistics
Market cap₩327.43b
Earnings (TTM)₩30.44b
Revenue (TTM)₩139.13b

10.8x

P/E Ratio

2.4x

P/S Ratio

Is A206640 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A206640 income statement (TTM)
Revenue₩139.13b
Cost of Revenue₩54.79b
Gross Profit₩84.34b
Other Expenses₩53.90b
Earnings₩30.44b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.39k
Gross Margin60.62%
Net Profit Margin21.88%
Debt/Equity Ratio4.3%

How did A206640 perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

14%

Payout Ratio